Indian-American billionaire arrested on racketeering charges

Image
Press Trust of India Washington
Last Updated : Oct 26 2017 | 11:13 PM IST
An Indian-American billionaire founder of a pharmaceutical company was arrested today in the US for allegedly leading a nationwide conspiracy to bribe doctors to prescribe a powerful opioid to patients who don't need it.
John Kapoor, 74, was taken into custody in Phoenix, Arizona. Kapoor is the founder and former CEO of the pharmaceutical company Insys Therapeutics. He faces charges including racketeering, conspiracy and fraud, CBS News reported.
Kapoor, who was born in Amritsar, is the most significant pharmaceutical executive to be criminally charged in response to the nationwide opioid crisis.
Brian Kelly, an attorney for Kapoor, said his client "is innocent of these charges and intends to fight the charges vigorously."
Kapoor stepped down as CEO of Insys in January but still serves on its board. The company makes a spray version of fentanyl, a highly addictive opioid intended only for cancer patients.
Authorities allege Insys marketed the drug as part of a scheme to get non-cancer doctors to prescribe it. Numerous physicians were allegedly paid bribes by the company to push the painkilling drug.
Kapoor is due to appear in US District Court in Phoenix.
Last December, six other Insys executives were indicted on federal charges in Boston in connection with the alleged scheme to bribe doctors to unnecessarily prescribe the painkilling drug.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 26 2017 | 11:13 PM IST

Next Story